Current Drug Targets - Inflammation & Allergy
Title: Preface (Hot Topic: Pulmonary Inflammation Guest Editor: Momtchilo Russo)
Volume: 2 Issue: 2
Author(s): Momtchilo Russo
Affiliation:
Export Options
About this article
Cite this article as:
Russo Momtchilo, Preface (Hot Topic: Pulmonary Inflammation Guest Editor: Momtchilo Russo), Current Drug Targets - Inflammation & Allergy 2003; 2 (2) . https://dx.doi.org/10.2174/1568010033484205
DOI https://dx.doi.org/10.2174/1568010033484205 |
Print ISSN 1568-010X |
Publisher Name Bentham Science Publisher |
Online ISSN 1568-010X |
21
Related Articles
-
Inhaled Hypertonic Saline as a Therapeutic Strategy to Dampen Inflammation in Cystic Fibrosis
Clinical Immunology, Endocrine & Metabolic Drugs (Discontinued) Synthesis and Biological Evaluation of New Piperazine Substituted 3, 5-Diarylisoxazolines
Current Organic Synthesis Household Typology and Family Social Capital Among White British and Pakistani Women in Bradford, England
Current Women`s Health Reviews Experimental Phage Therapies in Companion Animals with A Historical Review
Current Reviews in Clinical and Experimental Pharmacology Production and Degradation of Oxygen Metabolites During Inflammatory States in the Human Lung
Current Drug Targets - Inflammation & Allergy Hydrolases in Organic Chemistry. Recent Achievements in the Synthesis of Pharmaceuticals
Current Organic Chemistry Risks of Self-Medication Practices
Current Drug Safety TH2 Cytokines and Associated Transcription Factors as Therapeutic Targets in Asthma
Current Drug Targets - Inflammation & Allergy Protein Kinase C-theta Inhibitors: A Novel Therapy for Inflammatory Disorders
Current Pharmaceutical Design Adherence in Asthma
Current Respiratory Medicine Reviews Thymoquinone: Major Molecular Targets, Prominent Pharmacological Actions and Drug Delivery Concerns
Current Bioactive Compounds Tuberculosis, an Old Disease Lacking New Therapeutic Drugs
Current Drug Therapy Recombinant Protein Based Therapeutics for IPF
Inflammation & Allergy - Drug Targets (Discontinued) Designed Multiple Ligands: Basic Research vs Clinical Outcomes
Current Medicinal Chemistry Phosphorylation-Specific Prolyl Isomerase Pin1 as a new Diagnostic and Therapeutic Target for Cancer
Current Cancer Drug Targets Lung Dendritic Cells: Targets for Therapy in Allergic Disease
Current Molecular Medicine A Review of Pharmacological Properties and Toxicological Effects of Adiantum capillus-veneris L.
Current Drug Discovery Technologies Anti-Inflammatory Approaches that Target the Chemokine Network
Recent Patents on Inflammation & Allergy Drug Discovery The Applications of Biomarkers in Early Clinical Drug Development to Improve Decision-Making Processes
Current Clinical Pharmacology Monoclonal Antibodies: A Target Therapy for Multiple Sclerosis
Inflammation & Allergy - Drug Targets (Discontinued)